dream pharma ltd
dream pharma ltd Company Information
Company Number
04637884
Website
www.dreampharma.comRegistered Address
4a garside close, hampton, TW12 3AN
Industry
Wholesale of pharmaceutical goods
Telephone
-
Next Accounts Due
October 2025
Group Structure
View All
Directors
Mehdi Alavi21 Years
Shareholders
m. alavi 100%
dream pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of DREAM PHARMA LTD at £51.6k based on a Turnover of £119.7k and 0.43x industry multiple (adjusted for size and gross margin).
dream pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of DREAM PHARMA LTD at £0 based on an EBITDA of £-24.4k and a 3.38x industry multiple (adjusted for size and gross margin).
dream pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of DREAM PHARMA LTD at £2.2m based on Net Assets of £1m and 2.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dream Pharma Ltd Overview
Dream Pharma Ltd is a live company located in hampton, TW12 3AN with a Companies House number of 04637884. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in January 2003, it's largest shareholder is m. alavi with a 100% stake. Dream Pharma Ltd is a mature, micro sized company, Pomanda has estimated its turnover at £119.7k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dream Pharma Ltd Health Check
Pomanda's financial health check has awarded Dream Pharma Ltd a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
6 Weak
Size
annual sales of £119.7k, make it smaller than the average company (£22.7m)
- Dream Pharma Ltd
£22.7m - Industry AVG
Growth
3 year (CAGR) sales growth of -63%, show it is growing at a slower rate (5.8%)
- Dream Pharma Ltd
5.8% - Industry AVG
Production
with a gross margin of 11.8%, this company has a higher cost of product (22.2%)
- Dream Pharma Ltd
22.2% - Industry AVG
Profitability
an operating margin of -20.4% make it less profitable than the average company (3.7%)
- Dream Pharma Ltd
3.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (36)
1 - Dream Pharma Ltd
36 - Industry AVG
Pay Structure
on an average salary of £45.3k, the company has an equivalent pay structure (£45.3k)
- Dream Pharma Ltd
£45.3k - Industry AVG
Efficiency
resulting in sales per employee of £119.7k, this is less efficient (£774.9k)
- Dream Pharma Ltd
£774.9k - Industry AVG
Debtor Days
it gets paid by customers after 6 days, this is earlier than average (62 days)
- Dream Pharma Ltd
62 days - Industry AVG
Creditor Days
its suppliers are paid after 101 days, this is slower than average (38 days)
- Dream Pharma Ltd
38 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Dream Pharma Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Dream Pharma Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2.7%, this is a lower level of debt than the average (58.5%)
2.7% - Dream Pharma Ltd
58.5% - Industry AVG
DREAM PHARMA LTD financials
Dream Pharma Ltd's latest turnover from January 2024 is estimated at £119.7 thousand and the company has net assets of £1 million. According to their latest financial statements, Dream Pharma Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,086,966 | 844,229 | |||||||||||||
| Other Income Or Grants | 0 | 0 | |||||||||||||
| Cost Of Sales | 746,132 | 670,427 | |||||||||||||
| Gross Profit | 340,834 | 173,802 | |||||||||||||
| Admin Expenses | 89,004 | 79,342 | |||||||||||||
| Operating Profit | 251,830 | 94,460 | |||||||||||||
| Interest Payable | 0 | 68 | |||||||||||||
| Interest Receivable | 219 | 0 | |||||||||||||
| Pre-Tax Profit | 251,830 | 94,460 | |||||||||||||
| Tax | -50,486 | -19,860 | |||||||||||||
| Profit After Tax | 201,344 | 74,600 | |||||||||||||
| Dividends Paid | 60,000 | 32,798 | |||||||||||||
| Retained Profit | 141,344 | 41,802 | |||||||||||||
| Employee Costs | 15,600 | 10,480 | |||||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | ||||||||||
| EBITDA* | 252,429 | 97,477 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,071,088 | 1,071,088 | 1,071,088 | 2,080 | 2,773 | 3,698 | 4,931 | 1,796 | 2,395 | 3,194 | 4,259 | 1,917 | 2,556 | 6,789 | 9,051 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,071,088 | 1,071,088 | 1,071,088 | 2,080 | 2,773 | 3,698 | 4,931 | 1,796 | 2,395 | 3,194 | 4,259 | 1,917 | 2,556 | 6,789 | 9,051 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63,751 | 9,575 | 7,750 | 59,539 | 9,327 | 8,821 | 5,112 |
| Trade Debtors | 2,145 | 11,721 | 25,988 | 1,118,000 | 1,167,147 | 1,218,788 | 123,202 | 111,072 | 100,166 | 152,147 | 124,485 | 70,275 | 71,808 | 56,737 | 18,776 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,358 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 1,300,253 | 930,341 | 713,487 | 683,689 | 556,639 | 525,679 | 499,590 | 342,236 | 339,377 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,542 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,145 | 11,721 | 25,988 | 1,118,000 | 1,167,147 | 1,218,788 | 1,423,455 | 1,048,955 | 877,404 | 845,411 | 688,874 | 655,493 | 580,725 | 413,152 | 363,265 |
| total assets | 1,073,233 | 1,082,809 | 1,097,076 | 1,120,080 | 1,169,920 | 1,222,486 | 1,428,386 | 1,050,751 | 879,799 | 848,605 | 693,133 | 657,410 | 583,281 | 419,941 | 372,316 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 29,272 | 14,478 | 640 | 430 | 480 | 1,025 | 123,400 | 8,749 | 31,877 | 6,247 | 3,120 | 36,039 | 8,399 | 8,269 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 52,736 | 0 | 52,245 | 34,866 | 38,892 | 51,616 | 25,993 | 0 |
| total current liabilities | 29,272 | 14,478 | 640 | 430 | 480 | 1,025 | 123,400 | 61,485 | 31,877 | 58,492 | 37,986 | 74,931 | 60,015 | 34,262 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26,167 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26,167 |
| total liabilities | 29,272 | 14,478 | 640 | 430 | 480 | 1,025 | 123,400 | 61,485 | 31,877 | 58,492 | 37,986 | 74,931 | 60,015 | 34,262 | 26,167 |
| net assets | 1,043,961 | 1,068,331 | 1,096,436 | 1,119,650 | 1,169,440 | 1,221,461 | 1,304,986 | 989,266 | 847,922 | 790,113 | 655,147 | 582,479 | 523,266 | 385,679 | 346,149 |
| total shareholders funds | 1,043,961 | 1,068,331 | 1,096,436 | 1,119,650 | 1,169,440 | 1,221,461 | 1,304,986 | 989,266 | 847,922 | 790,113 | 655,147 | 582,479 | 523,266 | 385,679 | 346,149 |
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 251,830 | 94,460 | |||||||||||||
| Depreciation | 0 | 0 | 0 | 1,643 | 599 | 799 | 1,065 | 1,419 | 639 | 851 | 2,262 | 3,017 | |||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Tax | -50,486 | -19,860 | |||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -63,751 | 54,176 | 1,825 | -51,789 | 50,212 | 506 | 3,709 | 5,112 |
| Debtors | -9,576 | -14,267 | -1,092,012 | -49,147 | -51,641 | 1,095,586 | 12,130 | 10,906 | -51,981 | 27,662 | 54,210 | -1,533 | 9,713 | 43,319 | 18,776 |
| Creditors | 14,794 | 13,838 | 210 | -50 | -545 | -122,375 | 114,651 | -23,128 | 25,630 | 3,127 | -32,919 | 27,640 | 130 | 8,269 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | -52,736 | 52,736 | -52,245 | 17,379 | -4,026 | -12,724 | 25,623 | 25,993 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 284,396 | 53,729 | |||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26,167 | 26,167 |
| share issue | |||||||||||||||
| interest | 219 | -68 | |||||||||||||
| cash flow from financing | 219 | 330,446 | |||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | -1,300,253 | 369,912 | 216,854 | 29,798 | 127,050 | 30,960 | 26,089 | 157,354 | 2,859 | 339,377 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | -1,300,253 | 369,912 | 216,854 | 29,798 | 127,050 | 30,960 | 26,089 | 157,354 | 2,859 | 339,377 |
dream pharma ltd Credit Report and Business Information
Dream Pharma Ltd Competitor Analysis
Perform a competitor analysis for dream pharma ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.
dream pharma ltd Ownership
DREAM PHARMA LTD group structure
Dream Pharma Ltd has no subsidiary companies.
Ultimate parent company
DREAM PHARMA LTD
04637884
dream pharma ltd directors
Dream Pharma Ltd currently has 1 director, Mr Mehdi Alavi serving since Jan 2003.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mehdi Alavi | 63 years | Jan 2003 | - | Director |
P&L
January 2024turnover
119.7k
+5%
operating profit
-24.4k
0%
gross margin
11.8%
-3.08%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
1m
-0.02%
total assets
1.1m
-0.01%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
dream pharma ltd company details
company number
04637884
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
January 2003
age
21
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
4a garside close, hampton, TW12 3AN
last accounts submitted
January 2024
dream pharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dream pharma ltd.
dream pharma ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
